The global antibacterial drugs market revenue is expected to register a moderate CAGR over the forecast period. The rising prevalence of infectious diseases, increasing number of product approvals are major factors expected to support growth of the market over the forecast period. Increasing healthcare expenditure and recent advancements made in enteral routes of administration is in turn expected to support growth of the global antibacterial drugs market over the forecast period.

The global antibacterial drugs market report has been segmented on the basis of drug class, route of administration, distribution channel, and region.

Based on drug class, the global antibacterial drugs market is segmented based on B – lactams, quinolones, macrolides, tetracycline, aminoglycoside, sulfonamide, phenicols, and others.

Based on route of administration, the global antibacterial drugs market is segmented based on oral, topical, parenteral, and others.

Distribution channel is segment based on hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment accounts for major revenue share and is expected to register significant growth rate over the forecast period, owing to the ease of availability of the products.

Request for the Sample Report Here: https://marketresearch.biz/report/antibacterial-drugs-market/request-sample/

Regional segmentation includes North America, Europe, Latin America, Asia Pacific and Middle East and Africa. North America contributes major market share and is expected to maintain its dominance over the forecast period. Increasing number of product approvals and presence of significant number of players in the market are major factors expected to drive growth of market in the region over the forecast. Asia Pacific region is expected to witness rapid growth rate over the forecast period. Countries like India and China is expected to support the growth of the market in Asia Pacific region.

Some prominent players in the global antibacterial drugs market are Allergan, Plc., Novartis AG, Bristol Myers Squibb Company, Johnson and Johnson, AstraZeneca, Merck & Company, Inc., GlaxoSmithKline Plc., Sanofi SA, Pfizer Inc., and F. Hoffmann-La Roche AG.

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: